Gipson Debbie S, Pal Maisha, Desmond Hailey, Anderson Charles, Walsh Liron, Trachtman Howard, Massengill Susan F, Gipson Patrick, Rao Panduranga S, Thurman Joshua, Kopp Jeffrey, Kamil Elaine, Lamothe Jennifer, Mariani Laura H, LaFleur Paula, Vento Suzanne, O'Shaughnessy Michelle, Farag Youssef M K, Simon Christine, Carlozzi Noelle E
Department of Pediatrics/Pediatric Nephrology, University of Michigan, Ann Arbor, MI, USA.
Department of Pediatrics/Pediatric Nephrology, Levine Children's Hospital at Atrium Health, Charlotte, NC, USA.
Glomerular Dis. 2023 Jun 12;3(1):132-139. doi: 10.1159/000531505. eCollection 2023 Jan-Dec.
Edema is a common manifestation of proteinuric kidney diseases, but there is no consensus approach for reliably evaluating edema. The objective of this study was to develop an edema clinician-reported outcome measure for use in patients with nephrotic syndrome.
A literature review was conducted to assess existing clinician-rated measures of edema. Clinical experts were recruited from internal medicine, nephrology, and pediatric nephrology practices to participate in concept elicitation using semi-structured interviews and cognitive debriefing. Qualitative analysis methods were used to collate expert input and inform measurement development. In addition, training and assessment modules were developed using an iterative process that also utilized expert input and cognitive debriefing to ensure interrater reliability.
While several clinician-rated measures of edema have been proposed, our literature review did not identify any studies to support the reliability or validity of these measures. Fourteen clinician experts participated in the concept elicitation interviews, and twelve participated in cognitive debriefing. A clinician-reported outcome measure for edema was developed. The measure assesses edema severity in multiple individual body parts. An online training module and assessment tool were generated and refined using additional clinician input and investigative team expertise.
The Edema ClinRO (V1) measure is developed specifically to measure edema in nephrotic syndrome. The tool assesses edema across multiple body parts, and it includes a training module to ensure standardized administration across raters. Future examination of this measure is ongoing to establish its reliability and validity.
水肿是蛋白尿性肾脏疾病的常见表现,但目前尚无可靠评估水肿的共识方法。本研究的目的是开发一种用于肾病综合征患者的水肿临床医生报告结局指标。
进行文献综述以评估现有的临床医生评定的水肿指标。从内科、肾病科和儿科肾病科招募临床专家,通过半结构化访谈和认知反馈参与概念引出。采用定性分析方法整理专家意见并为测量指标的开发提供参考。此外,通过迭代过程开发培训和评估模块,该过程也利用专家意见和认知反馈以确保评分者间的可靠性。
虽然已经提出了几种临床医生评定的水肿指标,但我们的文献综述未发现任何支持这些指标可靠性或有效性的研究。14名临床医生专家参与了概念引出访谈,12名参与了认知反馈。开发了一种临床医生报告的水肿结局指标。该指标评估多个身体部位的水肿严重程度。利用更多临床医生的意见和研究团队的专业知识生成并完善了一个在线培训模块和评估工具。
水肿临床医生报告结局指标(V1版)是专门为测量肾病综合征中的水肿而开发的。该工具评估多个身体部位的水肿,并且包括一个培训模块以确保评分者之间的标准化管理。目前正在对该指标进行进一步研究以确定其可靠性和有效性。